The purpose of this latest RFI is to increase the USCG’s understanding of the level of maturity of the U.S. and allied nation ...

AstraZeneca Plc (NASDAQ:AZN) reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma.

In addition, there are some patients with very severe steroid-resistant asthma who continue to show uncontrolled eosinophil inflammation despite treatment with high-dose ICS. Apart from LTRA ...